0000875320-24-000133.txt : 20240503
0000875320-24-000133.hdr.sgml : 20240503
20240503162622
ACCESSION NUMBER: 0000875320-24-000133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240501
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Upadhyay Suketu
CENTRAL INDEX KEY: 0001533149
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 24913569
MAIL ADDRESS:
STREET 1: 345 E. MAIN STREET
CITY: WARSAW
STATE: IN
ZIP: 46580
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
wk-form4_1714767971.xml
FORM 4
X0508
4
2024-05-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001533149
Upadhyay Suketu
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
0
Common Stock
2024-05-01
4
A
0
1001
0
A
3727
D
Common Stock
2024-05-01
4
D
0
1168
D
2559
D
Deferred Stock Units
2024-05-01
4
A
0
1168
A
Common Stock
1168
1402.996
D
Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
Upon the vesting of restricted stock units granted to Mr. Upadhyay on May 1, 2023, Mr. Upadhyay deferred the receipt of 1,168 shares of common stock and received instead 1,168 deferred stock units pursuant to our deferred compensation plan. As a result, Mr. Upadhyay is reporting the disposition of 1,168 shares of common stock in exchange for an equal number of deferred stock units.
Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.
/s/ Christiana Stevenson, Attorney-in-Fact
2024-05-03